The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1118
ISSUE1118
November 12, 2001
Nesiritide For Decompensated Congestive Heart Failure
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Nesiritide For Decompensated Congestive Heart Failure
November 12, 2001 (Issue: 1118)
Nesiritide, a recombinant human B-type natriuretic peptide (BNP), has been approved by the FDA of intravenous (IV) treatment of patients with decompensated congestive heart failure who have dyspnea at rest or with minimal exertion (New York Heart...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.